ARCHIVES

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

This article is from The Cancer Letter archive.

Vol. 17 No. 41 | October 25, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Clinical Trials Working Group is looking for pragmatic solutions to improve cancer clinical trials system, Institute official says.

September 24, 2004

Pas Available; Alternative Medicine

January 21, 1994

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

Three Cooperative Groups To Combine Statistical Center Operations

July 2, 2010